ArticleOncotarget2017

Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine.

Rosalie M Sterner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.